357 results on '"Massad, L. Stewart"'
Search Results
2. Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care
3. Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy
4. Impact of employment and insurance status on distress in gynecologic oncology patients
5. A fellow-run clinic achieves similar patient outcomes as faculty clinics: A safe and feasible model for gynecologic oncology fellow education
6. Modified frailty index is predictive of wound complications in obese patients undergoing gynecologic surgery via a midline vertical incision
7. Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention
8. Patients with endometrial cancer continue to lack understanding of their risks for cancer
9. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
10. Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.
11. Declining Prevalence of Trichomonas vaginalis Diagnosed by Wet Mount in a Cohort of U.S. Women With and Without HIV.
12. Cervical Cancer Risk and Screening Among Women Seeking Assistance With Basic Needs
13. Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
14. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer
15. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women
16. A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results
17. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test
18. A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients
19. Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer
20. Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer
21. Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
22. Intestinal perforation in gynecologic oncology: Do all patients benefit from surgical management?
23. Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins
24. Cervical cancer incidence after up to 20 years of observation among women with HIV
25. Influence of Adherent and Effective Antiretroviral Therapy Use on Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Human Immunodeficiency Virus–Positive Women
26. Wound complications after gynecologic cancer surgery
27. Serum Immunoglobulin a Response to Human Papillomavirus Type 16 Virus-Like Particles in Human Immunodeficiency Virus (HIV)-Positive and High-Risk HIV-Negative Women
28. The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the Society of Gynecologic Oncologists
29. Infrequent methylation of the DUSP6 phosphatase in endometrial cancer
30. Knowledge of cervical cancer prevention and human papillomavirus among women with HIV
31. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients
32. Association of Vitamin A Deficiency with Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus-Infected Women
33. The value of perioperative imaging in patients with uterine sarcomas
34. Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: Interim Clinical Guidance
35. Long-term cumulative detection of human papillomavirus among HIV seropositive women
36. Trends in Bacterial Vaginosis Prevalence in a Cohort of U.S. Women with and at Risk for HIV.
37. Disclosing a Diagnosis of Cancer: Considerations Specific to Gynecologic Oncology Patients
38. Pathology correlates of a papanicolaou diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion
39. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type
40. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results
41. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. (Consensus Statement)
42. Trends in Contraceptive Use Among Women With Human Immunodeficiency Virus
43. Negative Predictive Value of Pap Testing: Implications for Screening Intervals for Women With Human Immunodeficiency Virus
44. Risk of Cervical Precancer and Cancer Among HIV-Infected Women With Normal Cervical Cytology and No Evidence of Oncogenic HPV Infection
45. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the Women's Interagency HIV Study
46. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
47. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
48. Outcome After Negative Colposcopy Among Human Immunodeficiency Virus–Infected Women With Borderline Cytologic Abnormalities
49. Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus–Positive Women
50. Highly Active Antiretroviral Therapy and Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus–Positive Women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.